Overview

A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India

Status:
No longer available

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The new protocol will allow the patients enrolled on A4001050 to have continuous access of Maraviroc and the treatment will not be interrupted until the drug is commercially available in India.

Details

Lead Sponsor:

ViiV Healthcare

Collaborator:

Pfizer

Treatments:

Maraviroc